Clark Capital Management Group, Inc. Emergent Bio Solutions Inc. Transaction History

Clark Capital Management Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 02, 2021	SELL	$56.61 - $80.46 $1.41 Million - $2.01 Million	-24,927 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$86.23 - $125.19 $11.8 Million - $17.2 Million	-137,059 Reduced 84.61%	24,927 $2.32 Million
Q4 2020 Jan 26, 2021	SELL	$79.17 - $111.47 $3.34 Million - $4.7 Million	-42,157 Reduced 20.65%	161,986 $14.5 Million
Q3 2020 Nov 12, 2020	BUY	$81.91 - $134.94 $13.7 Million - $22.5 Million	166,978 Added 449.29%	204,143 $21.1 Million
Q2 2020 Aug 14, 2020	BUY	$54.33 - $89.52 $2.02 Million - $3.33 Million	37,165 New	37,165 $2.94 Million
Q2 2018 Aug 14, 2018	SELL	$48.33 - $55.64 $2.17 Million - $2.49 Million	-44,826 Closed	0 $0
Q1 2018 May 08, 2019	SELL	$44.44 - $54.39 $166,561 - $203,853	-3,748 Reduced 7.72%	44,826 $2.36 Million
Q1 2018 May 15, 2018	SELL	$44.44 - $54.39 $1.27 Million - $1.56 Million	-28,671 Reduced 37.12%	48,574 $2.56 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $834,830 - $1.06 Million	22,103 Added 40.08%	77,245 $3.59 Million
Q3 2017 Nov 14, 2017	BUY	$34.14 - $40.45 $1.88 Million - $2.23 Million	55,142	55,142 $2.23 Million

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Clark Capital Management Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Clark Capital Management Group, Inc. with notifications on news.